FierceBiotech 2025-12-12 Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’
Endpoints News 2025-12-12 CHMP calls to reject Anavex's Alzheimer’s pill over impurities, side effects and weak efficacy
Endpoints News 2025-12-12 #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
FierceBiotech 2025-12-12 Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share
FierceBiotech 2025-12-12 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says
Agilent 2025-12-12 Strength in Technology Enabled Products Drives Roper: Can It Sustain? - The Globe and Mail